Safety evaluation of the food enzyme <i>β</i>-galactosidase from the genetically modified <i>Bacillus licheniformis</i> strain DSM 34099.

ABSTRACT: The food enzyme β-galactosidase (β-d-galactoside galactohydrolase; EC 3.2.1.23) is produced with the genetically modified Bacillus licheniformis strain DSM 34099 by Kerry Group Services International, Ltd. (KGSI). The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and its DNA. The production strain met the requirements for the qualified presumption of safety (QPS) approach. The food enzyme is intended to be used in two food manufacturing processes. Dietary exposure was estimated to be up to 7.263 mg total organic solids/kg body weight per day in European populations. Given the QPS status of the production strain and the absence of concerns resulting from the food enzyme manufacturing proce

SUBMITTER: EFSA panel on Food Enzymes (FEZ) 

PROVIDER: S-EPMC11303976 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature